CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- 4 Shares withheld for taxes Principal Accounting Officer gave up 1,016 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 2,471 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 1,040 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 821 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 818 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 876 shares (to pay taxes)
- 4 Open-market sale Principal Accounting Officer sold 152 shares at $76.45 ($11,620)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Financial Officer gave up 4,555 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 5,769 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 1,960 shares (to pay taxes)
- 4 Exercise or conversion Chief Scientific Officer acquired 20,500 shares (option exercise)
- 4 Gift Chief Executive Officer gave 1,000 shares (gift)
- 4 Open-market sale Chief Scientific Officer sold 3,000 shares at an average $69.69 ($209,071)
- 4/A Open-market sale Director sold 0 shares
- 4 Open-market sale Chief Scientific Officer sold 3,000 shares at an average $69.79 ($209,377)
- 4 Open-market sale Director sold 27,717 shares at an average $72.23 ($2,002,110)
- 4 Exercise or conversion Chief Executive Officer acquired 8,730 shares (option exercise)
- 4 Exercise or conversion Chief Executive Officer acquired 75,119 shares (option exercise)
- 4 Open-market sale Principal Accounting Officer sold 312 shares at $83.00 ($25,896)
Page 19 of 38 · 758 filings